Klisyri

Active Ingredient(s): Tirbanibulin
FDA Approved: * December 14, 2020
Pharm Company: * ALMIRALL
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Klisyri Overview

Tirbanibulin, sold under the brand name Klisyri, is a medication for the treatment of actinic keratosis on the face or scalp.[1][2] The most common side effects include local skin reactions, application site pruritus, and application site pain.[1][2] Tirbanibulin was approved for medical use in the United States in December 2020.[2][3][4] The U.S. Food and Drug Administration (FDA) ...

Read more Klisyri Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Tirbanibulin

Recent Klisyri Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Klisyri: (1 result)

Sorted by National Drug Code

• 16110-391 Klisyri 10 mg/g Topical Ointment by Almirall, LLC

Other drugs which contain Tirbanibulin or a similar ingredient: (1 result)

• TIRBANIBULIN